Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-29

Clinical Trial Update: FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy [Phase 3]

View source ↗

Summary

A Phase 3 FIREFLY trial evaluating fenofibrate as first-line therapy for Primary Biliary Cholangitis is currently recruiting. The trial is sponsored by Xijing H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Primary Biliary Cholangitis (PBC) | Phase 3 | Status: RECRUITING